1. Home
  2. PTGX vs ASTH Comparison

PTGX vs ASTH Comparison

Compare PTGX & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • ASTH
  • Stock Information
  • Founded
  • PTGX 2006
  • ASTH 1994
  • Country
  • PTGX United States
  • ASTH United States
  • Employees
  • PTGX N/A
  • ASTH N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • ASTH Professional Services
  • Sector
  • PTGX Health Care
  • ASTH Consumer Discretionary
  • Exchange
  • PTGX Nasdaq
  • ASTH Nasdaq
  • Market Cap
  • PTGX 2.8B
  • ASTH 2.2B
  • IPO Year
  • PTGX 2016
  • ASTH N/A
  • Fundamental
  • Price
  • PTGX $47.91
  • ASTH $55.47
  • Analyst Decision
  • PTGX Strong Buy
  • ASTH Strong Buy
  • Analyst Count
  • PTGX 7
  • ASTH 6
  • Target Price
  • PTGX $52.83
  • ASTH $64.40
  • AVG Volume (30 Days)
  • PTGX 450.1K
  • ASTH 269.1K
  • Earning Date
  • PTGX 11-08-2024
  • ASTH 11-07-2024
  • Dividend Yield
  • PTGX N/A
  • ASTH N/A
  • EPS Growth
  • PTGX N/A
  • ASTH 45.24
  • EPS
  • PTGX 2.75
  • ASTH 1.44
  • Revenue
  • PTGX $319,120,000.00
  • ASTH $1,591,829,000.00
  • Revenue This Year
  • PTGX $400.33
  • ASTH $33.99
  • Revenue Next Year
  • PTGX N/A
  • ASTH $24.43
  • P/E Ratio
  • PTGX $17.54
  • ASTH $38.79
  • Revenue Growth
  • PTGX 125.73
  • ASTH 22.76
  • 52 Week Low
  • PTGX $13.76
  • ASTH $28.87
  • 52 Week High
  • PTGX $48.89
  • ASTH $63.20
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 60.40
  • ASTH 47.69
  • Support Level
  • PTGX $45.33
  • ASTH $54.81
  • Resistance Level
  • PTGX $48.89
  • ASTH $57.09
  • Average True Range (ATR)
  • PTGX 1.28
  • ASTH 1.75
  • MACD
  • PTGX 0.11
  • ASTH -0.71
  • Stochastic Oscillator
  • PTGX 77.11
  • ASTH 22.13

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About ASTH Astrana Health Inc. Common Stock

Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Its operating segment is the healthcare delivery segment.

Share on Social Networks: